However, A549 cells treated with siRNAs targeting ADAMTS7 and DPP3, a gene not predicted to be involved in the NF-κB pathway, resulted in complete abrogation of NF-κB regardless of influenza infection. The gene discussed is NFKB1; the disease is influenza.